Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.
A GP has told how RSV symptoms can be “easily mistaken” for a cold – and revealed when it’s time to call an ambulance for ...
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
The Oneida County Health Department is warning residents about the growing number of cases of respiratory illnesses in the ...